Fintel reports that on April 13, 2023, RESEARCH CAPITAL CORPORATION maintained coverage of Theratechnologies (TSX:TH) with a Buy recommendation.
Analyst Price Forecast Suggests 591.53% Upside
As of April 6, 2023, the average one-year price target for Theratechnologies is $20.40. The forecasts range from a low of $20.20 to a high of $21.00. The average price target represents an increase of 591.53% from its latest reported closing price of $2.95.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Theratechnologies is $513MM, an increase of 529.79%. The projected annual non-GAAP EPS is $0.96.
What are Other Shareholders Doing?
Stifel Financial holds 358K shares representing 0.37% ownership of the company. In it's prior filing, the firm reported owning 356K shares, representing an increase of 0.39%. The firm decreased its portfolio allocation in TH by 65.71% over the last quarter.
Truvestments Capital holds 1K shares representing 0.00% ownership of the company. No change in the last quarter.
AIGH Capital Management holds 3,830K shares representing 3.96% ownership of the company. In it's prior filing, the firm reported owning 2,913K shares, representing an increase of 23.94%. The firm decreased its portfolio allocation in TH by 48.02% over the last quarter.
Cook Wealth Management Group holds 15K shares representing 0.02% ownership of the company. No change in the last quarter.
Toronto Dominion Bank holds 4K shares representing 0.00% ownership of the company. In it's prior filing, the firm reported owning 0K shares, representing an increase of 100.00%.
What is the Fund Sentiment?
There are 37 funds or institutions reporting positions in Theratechnologies. This is a decrease of 2 owner(s) or 5.13% in the last quarter. Average portfolio weight of all funds dedicated to TH is 0.07%, a decrease of 50.59%. Total shares owned by institutions increased in the last three months by 13.20% to 24,895K shares.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
